InvestorsHub Logo
Followers 27
Posts 1014
Boards Moderated 0
Alias Born 08/19/2016

Re: None

Saturday, 12/17/2016 12:21:29 PM

Saturday, December 17, 2016 12:21:29 PM

Post# of 403225
George I agree with your 10 BILLION!!!

Cellceutix has begun enrolling patients in a Phase 2b trial of Prurisol in moderate-to-severe Chronic Plaque Psoriasis, assessing the drug's efficacy at higher dosing regimens. Due to its mechanism of action, Prurisol may also have applicability in treating other autoimmune-based diseases, such as Psoriatic Arthritis and Rheumatoid Arthritis.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News